Long Run Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$458K Buy
426
+145
+52% +$139K 0.09% 79
2025
Q3
$214K Hold
281
0.04% 103
2025
Q2
$219K Buy
281
+1
+0.4% +$777 0.05% 98
2025
Q1
$232K Buy
+280
New +$233K 0.05% 95
2024
Q4
Sell
-232
Closed -$206K 108
2024
Q3
$206K Buy
232
+1
+0.4% +$899 0.05% 101
2024
Q2
$209K Buy
+231
New +$185K 0.05% 98

Other funds holding LLY

Long Run Wealth Advisors's LLY Position: Q4 2025 in Review

Long Run Wealth Advisors increased its Eli Lilly (LLY) stake by 52% in Q4 2025, buying an estimated $139K and bringing the position to 426 shares worth $458K. The position accounts for 0.09% of the portfolio, ranked #79.

Long Run Wealth Advisors first reported a position in LLY in Q2 2024 and has held it in 6 quarters since. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Long Run Wealth Advisors held 426 shares of Eli Lilly worth $458K as of Q4 2025.
  • Long Run Wealth Advisors bought 145 Eli Lilly shares in Q4 2025, an estimated $139K.
  • Eli Lilly made up 0.09% of Long Run Wealth Advisors's portfolio in Q4 2025, its #79 holding.
  • Long Run Wealth Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 6 quarters since.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Long Run Wealth Advisors's 13F filing for Q4 2025, filed 2 Feb 2026.